-
-
Call more information
660-596-2224 -
ASA Monitor May 2024, Vol. 88, 27. AstraZeneca has announced the availability of its inhaled, fixed-dose combination rescue medication Airsupra® (albuterol/budesonide) in the U.S. by prescription, following FDA approval in January 2023. Airsupra is indicated for the as-needed treatment or prevention of asthma symptoms and to prevent sudden severe breathing problems, such as asthma attacks, in adults […]
Read MoreAuthors: George Tewfik, MD, MBA, FASA; Raymond Malapero, MD, MPH, FASA ASA Monitor May 2024, Vol. 88, e2–e3. If you have worked in any health care system, you have almost certainly heard these phrases uttered during your work experience: “That’s how it’s always been done.” “That’s what the surgeon likes.” “But your colleagues do it that way.” […]
Read MoreASA Monitor May 2024, Vol. 88, 12. A 61 y/o male was admitted with acute onset of stroke. Neuroradiologic imaging confirmed a thrombotic etiology, and alteplase was administered. The patient was emergently brought to an interventional suite for definitive treatment. He was intubated by the anesthesia team consisting of an attending anesthesiologist and a CRNA. The […]
Read MoreASA Monitor May 2024, Vol. 88, 27. Researchers at the National Institutes of Health (NIH) investigated the immune system responses and microbiome changes in individuals who switched between a vegan and ketogenic (keto) diet over two-week periods. They found that the vegan diet stimulated innate immunity, while the keto diet triggered adaptive immune responses. The study […]
Read MoreASA Monitor May 2024, Vol. 88, 27. The CEREGLIDE™ 71 Intermediate Catheter with TruCourse™ from Cerenovus, Inc., a division of Johnson & Johnson MedTech, is now available in the United States. The catheter is designed for the revascularization of acute ischemic stroke patients and facilitates direct aspiration and compatible stent retriever delivery, aiding in restoring blood […]
Read MoreAuthors: Dibash Kumar Das, PhD; Steven L. Shafer, MD, FASA ASA Monitor May 2024, Vol. 88, 1–5. Since its introduction almost 40 years ago, propofol has been adopted worldwide as the intravenous anesthetic of choice, with alternatives such as ketamine and etomidate limited to unusual indications. However, propofol has several common adverse effects, including pain on injection […]
Read MoreASA Monitor May 2024, Vol. 88, 10. Your next patient is a 55-year-old man with chronic kidney disease who is presenting for kidney transplantation from a deceased donor. Your resident asks about the use of intravenous (I.V.) balanced crystalloid solution for perioperative volume resuscitation. According to a recent study, which of the following MOST likely describes […]
Read MoreAuthor: Vishal Uppal, MBBS, MSc, FRCA ASA Monitor May 2024, Vol. 88, 1–9. When compared with general anesthesia (GA), patients undergoing surgery solely under peripheral nerve blocks (PNBs) are more likely to have improved short-term postoperative pain control, less nausea and vomiting, early discharge from the postanesthesia care unit and hospital, and overall improved patient satisfaction […]
Read MoreAuthor: David P. Martin, MD, PhD, FASA ASA Monitor May 2024, Vol. 88, 7–8. The largest group of committees and editorial boards within ASA resides in the Division of Scientific Affairs, comprising the sections on Publications, Clinical Care, Subspecialties, Education and Research, and the Annual Meeting. Last year in this column, space allowed us to review […]
Read MoreASA Monitor May 2024, Vol. 88, 27. The U.S. Food and Drug Administration (FDA) has granted approval to Thirona’s LungQ™ AI-based clinical software, making it one of few FDA-cleared solutions able to automatically segment pulmonary structures, aiding in lung diagnosis and documentation. LungQ’s analysis improves the understanding of lung anatomy, facilitating minimally invasive treatments for diseases […]
Read More